Global Medical REIT Inc. (GMRE) Expected to Post Quarterly Sales of $10.33 Million
Wall Street analysts predict that Global Medical REIT Inc. (NYSE:GMRE) will post $10.33 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Global Medical REIT’s earnings, with estimates ranging from $10.24 million to $10.41 million. Global Medical REIT reported sales of $3.12 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 231.1%. The business is scheduled to report its next earnings results on Monday, March 26th.
On average, analysts expect that Global Medical REIT will report full year sales of $10.33 million for the current financial year, with estimates ranging from $30.71 million to $30.88 million. For the next fiscal year, analysts expect that the business will post sales of $55.72 million per share, with estimates ranging from $54.26 million to $57.17 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Global Medical REIT.
GMRE has been the subject of several research analyst reports. Zacks Investment Research lowered Global Medical REIT from a “hold” rating to a “sell” rating in a report on Tuesday, November 7th. DA Davidson downgraded Global Medical REIT from a “buy” rating to a “neutral” rating and reduced their target price for the company from $11.00 to $10.00 in a report on Tuesday, August 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $12.00 target price on shares of Global Medical REIT in a report on Friday, September 1st. B. Riley reaffirmed a “buy” rating and set a $10.50 target price on shares of Global Medical REIT in a report on Friday, November 10th. Finally, FBR & Co reaffirmed a “buy” rating and set a $10.50 target price (up from $10.00) on shares of Global Medical REIT in a report on Monday, September 18th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $10.60.
Shares of Global Medical REIT (NYSE GMRE) traded down $0.05 during trading on Friday, hitting $9.34. The stock had a trading volume of 72,617 shares, compared to its average volume of 87,455. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.22 and a current ratio of 0.22. The firm has a market capitalization of $202.03, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 2.97 and a beta of -0.71. Global Medical REIT has a twelve month low of $7.12 and a twelve month high of $10.25.
Global Medical REIT Company Profile
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Global Medical REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc. and related stocks with our FREE daily email newsletter.